Eterna Therapeutics Announces Expansion of Scientific Advisory Board
CAMBRIDGE, Mass., Jan. 28, 2025 (GLOBE NEWSWIRE) -- Eterna Therapeutics (Nasdaq: ERNA), a leader in cell therapies for the treatment of advanced solid tumors, today announced the addition of Jerome ...
AZoNano on MSN4h
New Nanosystem Offers Precision Targeting and Therapy for Tongue Cancer
The Au-HN-1 nanosystem represents a breakthrough in TSCC treatment, integrating targeted photothermal therapy with advanced ...
Sonnet BioTherapeutics Further Expands Global Intellectual Property Portfolio with Issuance of EU Patent for FHAB® Platform Technology
European Patent Office (EPO) grants EU Patent No. EP3583125 B1 covering the Company’s Fully Human Albumin Binding (FHAB®) domain fusion ...
MarketWatch18h
Xilio Therapeutics Inc.
Roche Holding AG Akt 0.90% CHF221.01B ...